AccuStem Sciences, Inc.
ACUT
$0.16
-$0.07-28.89%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 98.40K | -- | -- | -- | -- |
| Total Revenue | 98.40K | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 98.40K | -- | -- | -- | -- |
| SG&A Expenses | 307.30K | 366.40K | 394.60K | 327.20K | 341.20K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 351.00K | 485.90K | 514.40K | 399.90K | 401.40K |
| Operating Income | -252.60K | -485.90K | -514.40K | -399.90K | -401.40K |
| Income Before Tax | -252.60K | -485.90K | -514.40K | -399.90K | -401.40K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -252.60K | -485.90K | -514.40K | -399.90K | -401.40K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -252.60K | -485.90K | -514.40K | -399.90K | -401.40K |
| EBIT | -252.60K | -485.90K | -514.40K | -399.90K | -401.40K |
| EBITDA | -252.50K | -485.80K | -514.40K | -399.90K | -401.30K |
| EPS Basic | -0.02 | -0.03 | -0.03 | -0.02 | -0.03 |
| Normalized Basic EPS | -0.01 | -0.02 | -0.02 | -0.02 | -0.02 |
| EPS Diluted | -0.02 | -0.03 | -0.03 | -0.02 | -0.03 |
| Normalized Diluted EPS | -0.01 | -0.02 | -0.02 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 16.07M | 16.07M | 16.08M | 16.07M | 16.07M |
| Average Diluted Shares Outstanding | 16.07M | 16.07M | 16.08M | 16.07M | 16.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |